Will it trade high? Cannabis biotech Zynerba Pharmaceuticals sets terms for $42 million IPO

24 July 2015 Editor Leave a comment

Zynerba Pharmaceuticals, a preclinical biotech developing cannabinoid-based therapies for osteoarthritis and epilepsy, announced terms for its IPO … …read more

Dagga Magazine

Will it trade high? Cannabis biotech Zynerba Pharmaceuticals sets terms for $42 million IPO

Leave a Reply Cancel reply

Latest South African Dagga Culture, Activism, Alternative News & Trends – AmaDaggafarian